• Alibaba on its RMB28.2 billion investment in Suning Commerce Group and Suning’s RMB14 billion investment in Alibaba.
  • Philips on its acquisition of the POVOS kitchen appliance business for RMB2.2 billion.
  • GE on its RMB3.3 billion investment in China XD Electric Co. and joint venture with XD. This was the first successful strategic investment by a U.S. Fortune 500 company in a Chinese-listed company.
  • Swire Beverage on its acquisition of bottling operations from The Coca-Cola Company and COFCO, also involving disposals of some bottling operations to COFCO, at a net cost of RMB4.6 billion.
  • The Hershey Company on its RMB2.4 billion purchase of Shanghai Golden Monkey Food Co.
  • Tyson Foods, Inc. in connection with the Hong Kong and China components of a deal to acquire MFG (USA) Holdings, Inc. and McKey Luxembourg Holdings.
  • Starbucks Corporation on its acquisition of a 50% stake in Shanghai Starbucks Coffee (a JV) for US$1.3 billion.
  • China Resources Enterprise on its acquisition of Tesco’s China retail business and the resulting formation of a joint venture.
  • Envision on its global acquisition of Automotive Energy Supply Corporation (AESC), Nissan’s worldwide car battery business, and on Envision’s joint venture with Nissan in a transaction valued at more than US$1 billion.
  • CITIC Group and its subsidiary CITIC Dicastal Co. on their US$300 million acquisition of KSM Castings
  • Tianjin Tianhai Investment Co., an A-share listed company, on its US$6 billion acquisition of Ingram Micro Inc., a NYSE-listed company.
  • Shanghai Electric Group on its acquisition of a 40% stake in Ansaldo Energia, a power engineering company in Italy, for €400 million.
  • UBS on its US$2 billion pre-IPO investment in Postal Savings Bank of China and on its US$500 million investment in the Bank of China.
  • The Royal Bank of Scotland, as the lead consortium investor, on the US$3.1 billion acquisition of a 10% stake in the Bank of China.
  • Citibank on the US$3 billion acquisition of a stake in Guangdong Development Bank.
  • P. Morgan Securities (Asia Pacific) on its establishment of a joint venture company in China.
  • China Construction Bank on its acquisition of Bankco WestLB do Brasil.
  • Bayer on its acquisition of Dihon Pharmaceutical Group for RMB3.6 billion.
  • China Everbright on its acquisition of 22.4% of the shares in LifeTech, a leading cardiovascular device manufacturer in China.
  • Bluesail Medical Co. on its acquisition of 93% of the shares in Biosensors International, a medical device company, for RMB5.9 billion.